1. Home
  2. NTRA vs TS Comparison

NTRA vs TS Comparison

Compare NTRA & TS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$277.90

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Logo Tenaris S.A.

TS

Tenaris S.A.

HOLD

Current Price

$53.86

Market Cap

29.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
TS
Founded
2003
2001
Country
United States
Luxembourg
Employees
N/A
24875
Industry
Medical Specialities
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
29.8B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
TS
Price
$277.90
$53.86
Analyst Decision
Strong Buy
Buy
Analyst Count
15
5
Target Price
$259.07
$58.80
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
2.80%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$18.08
$1.53
Revenue Next Year
$19.65
$3.59
P/E Ratio
N/A
$12.59
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$33.71
52 Week High
$279.42
$64.60

Technical Indicators

Market Signals
Indicator
NTRA
TS
Relative Strength Index (RSI) 78.21 30.72
Support Level $186.96 $51.85
Resistance Level N/A $55.02
Average True Range (ATR) 13.08 1.25
MACD 4.73 -0.57
Stochastic Oscillator 99.56 6.48

Price Performance

Historical Comparison
NTRA
TS

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

Share on Social Networks: